Enhancing natural killer cells is beneficial in multiple sclerosis

Abstract

Get full access to this article

View all access options for this article.

References

Oger

Kastrukoff

et al . Multiple sclerosis: In relapsing patients, immune functions vary with disease activity as assessed by MRI. Neurology 1988; 38: 1739–1744.

Shi

Zhu

et al . Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis. J Neuroimmunol 2014; 276: 180–186.

Wuest

Edwan

Martin

et al . A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat Med 2011; 17: 604–609.

Zhang

Yamamura

Kondo

et al . Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186: 1677–1687.

Ikizawa

et al . Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007; 26: 593–604.

Hao

Campagnolo

Liu

et al . Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Ann Neurol 2011; 69: 721–734.

Hao

Liu

Piao

et al . Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 2010; 207: 1907–1921.

Liu

Sanai

Jin

et al . Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation. Nat Neurosci 2016; 19: 243–252.

Enhancing natural killer cells is beneficial in multiple sclerosis – No

Abstract

Get full access to this article

References